Down to Coverage | GenomeWeb

Down to Coverage

While many US insurance companies will pay for BRCA 1 or BRCA 2 testing in a patient with a family history of breast or ovarian cancer, NPR's Shots blog reports that insurers often "balk at providing coverage" for tests examining other mutations linked to breast or ovarian cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.